ArticleCureus2025
Metastatic Adnexal Adenocarcinoma: A Case Report of Successful Treatment With Carboplatin and Paclitaxel.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Case Report: hidradenocarcinoma presenting with lymph node metastasis: a diagnostic challenge and the pivotal role of morphology.Frontiers in oncology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Metastatic adnexal adenocarcinoma not otherwise specified (AANOS) is a rare and aggressive tumor with little evidence about treatment options. We describe a case of metastatic AANOS that showed a positive response to carboplatin and paclitaxel. This response is novel in the current medical literature. We report the case of a 72-year-old male with no significant past medical history, presenting with a 4 cm occipito-temporal skin mass. A cutaneous biopsy and staging confirmed the diagnosis of primary cutaneous AANOS, with no evidence of metastasis. The patient underwent radical surgical excision followed by adjuvant radiotherapy. After 44 months of follow-up, the disease recurred locally and progressed with pulmonary, mediastinal, and bone metastases. The patient was started on a systemic chemotherapy regimen of carboplatin and paclitaxel. A near-complete response was observed after three months, which was sustained after one year of follow-up. Given the rarity of these tumors, no treatment guidelines are available, and evidence is based on single case reports and a few case series. A combination of carboplatin and paclitaxel provides a strong inhibition of cell mitosis and allows for the administration of lower doses at a higher frequency, thus balancing efficacy with reduced toxicity. Combination carboplatin and paclitaxel can be an effective treatment for metastatic AANOS.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.